Quantum-Si’s (QSI) “Buy” Rating Reaffirmed at HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Tuesday, MarketBeat Ratings reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 303.23% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Weiss Ratings upgraded Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday. Wall Street Zen raised Quantum-Si from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Finally, Alliance Global Partners reaffirmed a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $2.50.

Quantum-Si Stock Up 24.8%

Quantum-Si stock traded up $0.20 during mid-day trading on Tuesday, reaching $0.99. 19,744,222 shares of the company’s stock were exchanged, compared to its average volume of 4,400,892. Quantum-Si has a twelve month low of $0.69 and a twelve month high of $3.10. The company has a market cap of $217.13 million, a P/E ratio of -2.16 and a beta of 3.25. The company has a fifty day moving average of $0.77 and a 200-day moving average of $0.87.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The business had revenue of $0.34 million during the quarter, compared to the consensus estimate of $0.30 million. Equities research analysts expect that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Institutional Trading of Quantum-Si

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. IPG Investment Advisors LLC purchased a new stake in shares of Quantum-Si during the 2nd quarter worth approximately $27,000. Corient Private Wealth LP acquired a new stake in Quantum-Si during the 2nd quarter worth $34,000. Hollencrest Capital Management lifted its position in Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after acquiring an additional 30,111 shares during the last quarter. Green Alpha Advisors LLC purchased a new stake in Quantum-Si in the second quarter valued at $41,000. Finally, WINTON GROUP Ltd acquired a new position in Quantum-Si in the second quarter valued at $67,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.